Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01166776 · ClinicalTrials.gov registry record
A Research Study Looking at Specific Tissue of the Umbilical Cord
A clinical trial, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- 64
- Enrollment target
NCT01166776: Completed study, sponsored by University of Kansas Medical Center.
NCT01166776 is a clinical trial that has completed, run by University of Kansas Medical Center. The registered enrollment target is 64 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01166776 has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- 64 participants
- Enrollment target
Study Summary
The purpose of this study is to isolate Umbilical cord Wharton's jelly matrix to be used as a scaffold for tissue regenerative applications, including avascular necrosis.
Primary Outcome
Use the Wharton's Jelly matrix as a scaffold, we should be able to remove the cellular components of Wharton's Jelly. This decellularization process will help decrease antigenicity and accordingly avoid allosensitization. Additionally, the matrix should be able to provide a 3 dimensional (3D) environment needed for biologic and geometric recellularization.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2010-06 |
| Est. Completion | 2016-07 |
What the finished NCT01166776 record still lists
NCT01166776 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 64 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01166776 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01166776 about?
NCT01166776 is a clinical study titled "A Research Study Looking at Specific Tissue of the Umbilical Cord". The purpose of this study is to isolate Umbilical cord Wharton's jelly matrix to be used as a scaffold for tissue regenerative applications, including avascular necrosis.
What is the current status of trial NCT01166776?
This trial is currently completed. The enrollment target is 64 participants. The study started on 2010-06. Estimated completion is 2016-07.
Who is sponsoring clinical trial NCT01166776?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia